Decreased Odds for Vasospasm Treatment in Patients with Aneurysmal Subarachnoid Hemorrhage after Transitioning from Neurosurgery Led Care to a Neurology Led Multidisciplinary Approach.


Journal

Journal of vascular and interventional neurology
ISSN: 1941-5893
Titre abrégé: J Vasc Interv Neurol
Pays: United States
ID NLM: 101511381

Informations de publication

Date de publication:
May 2019
Historique:
entrez: 17 7 2019
pubmed: 17 7 2019
medline: 17 7 2019
Statut: ppublish

Résumé

The limited research on the management of aneurysmal subarachnoid hemorrhages (aSAHs) has not assessed the efficacy of neurology-led care. Our objective was to describe aSAH patients' outcomes after transitioning from a neurosurgery-led intensive care unit (ICU) to a neurology-led multidisciplinary care neurocritical care unit (NCCU). The study hypothesis was that the neurology-led multidisciplinary care would improve patient outcomes. This was a retrospective cohort study. We included patients (≥ 18) with aSAHs from 1/16 to 8/16 (pregroup) and from 3/17 to 11/17 (postgroup). The pregroup care was led by a neurosurgeon. The postgroup care included a neurologist, a pulmonary intensivist, a neurocritical care clinical nurse specialist, a neurosurgeon, and euvolemia protocol. The primary outcome was trips to interventional radiology (IR) for vasospasm treatment. Univariate analyses and multivariable ordinal logistic regression were used. There were 99 patients included: 50 in the pregroup and 49 in the postgroup. On average, postgroup patients were 7 years older than the pregroup ( In aSAH patients, the neurology-led multidisciplinary care in the NCCU decreased the odds of repeated procedures for vasospasm treatment. Neurology-led multidisciplinary care could be more cost-effective than the neurosurgical-led care.

Identifiants

pubmed: 31308868
pmc: PMC6613482

Types de publication

Journal Article

Langues

eng

Pagination

30-33

Références

Neurosurgery. 2008 Mar;62(3):610-7; discussion 610-7
pubmed: 18301345
J Neurosurg. 2010 Mar;112(3):626-30
pubmed: 19731990
Crit Care. 2010;14(1):R23
pubmed: 20175912
Stroke. 2010 Oct;41(10):2391-5
pubmed: 20798370
Neurocrit Care. 2011 Jun;14(3):334-40
pubmed: 21424884
Stroke. 2012 Jun;43(6):1711-37
pubmed: 22556195
J Neurosurg. 2014 Feb;120(2):391-7
pubmed: 24313610
Hosp Pharm. 2014 Nov;49(10):923-41
pubmed: 25477565
J Crit Care. 2016 Apr;32:52-5
pubmed: 26703419
Crit Care. 2016 Oct 14;20(1):277
pubmed: 27737684
Expert Opin Investig Drugs. 2018 Apr;27(4):313-324
pubmed: 29600883
AJNR Am J Neuroradiol. 1995 Jan;16(1):27-38
pubmed: 7900600
J Neurosurg. 1998 Feb;88(2):277-84
pubmed: 9452236

Auteurs

Russell Bartt (R)

Blue Sky Neurology, Swedish Medical Center.
Neurology, Swedish Medical Center.

Stephanie Jarvis (S)

Trauma Research.

Lauren Cittadino (L)

Neurology, Swedish Medical Center.

Benjamin Atchie (B)

Neurology, Swedish Medical Center.

Kathryn McCarthy (K)

Neurology, Swedish Medical Center.

Rebecca van Vliet (R)

Neurology, Swedish Medical Center.

Alicia Bennett (A)

Blue Sky Neurology, Swedish Medical Center.
Neurology, Swedish Medical Center.

Jeffrey Wagner (J)

Blue Sky Neurology, Swedish Medical Center.
Neurology, Swedish Medical Center.

Alessandro Orlando (A)

Trauma Research.

David Bar-Or (D)

Trauma Research.

Classifications MeSH